Inflammatory Bowel Diseases: From Bench to Bedside : Proceedings of the Falk Symposium No. 96 (Part IV of the Gastroenterology Symposia 1996) Held in Freiburg-im-Breisgau, Germany, October 30-November 1, 1996T. Andus |
From inside the book
Results 1-3 of 49
Page 46
... relapse rate after 12 months follow - up was 28 % in those treated with fish oil compared with 69 % in the placebo group ( dif- ference in relapse rate , 41 percentage points ; 95 % confidence interval 21-61 ; p < 0.001 ; Figure 1a ) ...
... relapse rate after 12 months follow - up was 28 % in those treated with fish oil compared with 69 % in the placebo group ( dif- ference in relapse rate , 41 percentage points ; 95 % confidence interval 21-61 ; p < 0.001 ; Figure 1a ) ...
Page 296
... relapse of the disease over the follow - up period was compared by life - table procedures . Relapse was defined as the occur- rence of ' active , symptomatic colitis or asymptomatic worsening of disease as assessed by sigmoidoscopy ...
... relapse of the disease over the follow - up period was compared by life - table procedures . Relapse was defined as the occur- rence of ' active , symptomatic colitis or asymptomatic worsening of disease as assessed by sigmoidoscopy ...
Page 318
... relapse . Patients received either 2.7 g n - 3 fatty acid or placebo . Of the 39 patients in the fish oil group 11 ( 28 % ) relapsed whereas in the placebo group 27/39 ( 69 % ) relapsed . After 1 year 23 ( 59 % ) in the fish oil group ...
... relapse . Patients received either 2.7 g n - 3 fatty acid or placebo . Of the 39 patients in the fish oil group 11 ( 28 % ) relapsed whereas in the placebo group 27/39 ( 69 % ) relapsed . After 1 year 23 ( 59 % ) in the fish oil group ...
Contents
new data | 5 |
Current and future parameters for stratification | 13 |
Genetic and chemical models of inflammatory bowel | 21 |
Copyright | |
44 other sections not shown
Common terms and phrases
acid active Crohn's disease acute adhesion molecules antibody antigens associated azathioprine bacterial budesonide cancer CD4+ T cells chronic Clin clinical colectomy colitis and Crohn's collagen colonic controlled trial corticosteroids Crohn's disease cyclosporine cytokines disease activity dose drugs dysplasia effect elemental diet endoscopic enemas expression fibroblasts fistulae function Gastroenterol Gastroenterology gastrointestinal gene genetic growth factor human IFN-y ileal ileostomy ileum immune Immunol increased induced inflammation inflammatory bowel disease inhibition integrins interleukin intestinal epithelial cells intestinal inflammation lamina propria lesions levels lymphocytes macrophages mast cells measles mediators mesalazine metabolism metronidazole mice mucosal normal oral pathogenesis patients with Crohn's patients with inflammatory patients with ulcerative peptide placebo pouch pouchitis prednisolone proctocolectomy production protein recent receptor recurrence relapse remission resection response risk role short bowel syndrome small bowel small intestine steroid stimulation studies sulphasalazine surgery therapeutic therapy tissue TNF-a treatment tumor necrosis ulcerative colitis